Anticoagulants and platelet-active agents in the secondary prevention of coronary artery disease.
D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects*; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology; D004176:Dipyridamole / Q000627:therapeutic use; D011464:Epoprostenol / Q000096:biosynthesis; D006801:Humans; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy / Q000401:mortality; D009426:Netherlands; D012008:Recurrence; D013442:Sulfinpyrazone / Q000627:therapeutic use
D000925:Anticoagulants; D004176:Dipyridamole; D011464:Epoprostenol; D001241:Aspirin; D013442:Sulfinpyrazone